Các yếu tố ảnh hưởng đến quá trình hồi phục và tiến triển của gãy xương đùi không điển hình chưa hoàn chỉnh được điều trị bảo tồn: Nghiên cứu quan sát hồi cứu

Koh A, Guerado E, Giannoudis PV (2017) Atypical femoral fractures related to bisphosphonate treatment: Issues and controversies related to their surgical management. Bone Jt J 99B:295–302. https://doi.org/10.1302/0301-620X.99B3.BJJ-2016-0276.R2 Lai YS, Chau JYM, Woo SB, Fang C, Lau TW, Leung F (2019) A retrospective review on atypical femoral fracture: operative outcomes and the risk factors for failure. Geriatr Orthop Surg Rehabil 10:215145931986473. https://doi.org/10.1177/2151459319864736 Teo BJX, Koh JSB, Goh SK, Png MA, Chua DTC, Howe TS (2014) Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Jt J 96:658–664 Bogdan Y, Tornetta P, Einhorn TA, Guy P, Leveille L et al (2016) Healing time and complications in operatively treated atypical femur fractures associated with bisphosphonate use: a multicenter retrospective cohort. J Orthop Trauma 30:177–181. https://doi.org/10.1097/BOT.0000000000000516 Schilcher J (2015) High revision rate but good healing capacity of atypical femoral fractures. A comparison with common shaft fractures. Injury 46:2468–2473. https://doi.org/10.1016/j.injury.2015.09.031 Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research. J Bone Miner Res 29:1–23. https://doi.org/10.1002/jbmr.1998 Chiang CY, Zebaze RMD, Ghasem-Zadeh A, Iuliano-Burns S, Hardidge A, Seeman E (2013) Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 52:360–365. https://doi.org/10.1016/j.bone.2012.10.006 Yoon BH, Kim KC (2020) Does teriparatide improve fracture union?: a systematic review. J Bone Metab 27:167–174 Pietrogrande L, Raimondo E (2013) Teriparatide in the treatment of non-unions: Scientific and clinical evidences. Injury 44:S54–S57. https://doi.org/10.1016/S0020-1383(13)70013-5 Saleh A, Hegde VV, Potty AG, Schneider R, Cornell CN, Lane JM (2012) Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures. HSS J 8:103–110. https://doi.org/10.1007/s11420-012-9275-y Gomberg SJ, Wustrack RL, Napoli N, Arnaud CD, Black DM (2011) Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. J Clin Endocrinol Metab 96:1627–1632. https://doi.org/10.1210/jc.2010-2520 Huang HT, Kang L, Huang PJ, Fu YC, Lin SY, Hsieh CH, Chen JC, Cheng YM, Chen CH (2012) Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report. Menopause 19:1360–1363. https://doi.org/10.1097/gme.0b013e318260143d Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y (2008) Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 42:90–97. https://doi.org/10.1016/j.bone.2007.08.041 Jahng JS, Kim HW (2000) Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics 23:1089–1094 Huang T-W, Chuang P-Y, Lin S-J, Lee C-Y, Huang K-C, Shih H-N, Lee MS, Hsu RWW, Shen W-J (2016) Teriparatide improves fracture healing and early functional recovery in treatment of osteoporotic intertrochanteric fractures. Medicine. https://doi.org/10.1097/MD.0000000000003626 Bhandari M, Jin L, See K, Burge R, Gilchrist N et al (1999) Does teriparatide improve femoral neck fracture healing: results from a randomized placebo-controlled trial. Clin Orthop Relat Res 474:1234–1244. https://doi.org/10.1007/s11999-015-4669-z Takakubo Y, Ohta D, Ishi M, Ito J, Oki H et al (2017) The incidence of atypical femoral fractures in patients with rheumatic disease: yamagata prefectural committee of atypical femoral fractures (YamaCAFe) study. Tohoku J Exp Med 242:327–334. https://doi.org/10.1620/tjem.242.327 Lee Y-K, Ha Y-C, Kang BJ, Chang JS, Koo K-H (2013) Predicting need for fixation of atypical femoral fracture. J Clin Endocrinol Metab 98:2742–2745. https://doi.org/10.1210/jc.2012-4322 Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y (2015) Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab. https://doi.org/10.1007/s00774-014-0617-3 van de Laarschot DM, McKenna MJ, Abrahamsen B, Langdahl B, Cohen-Solal M, Guañabens N, Eastell R, Ralston SH, Zillikens MC (2020) Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue society. J Clin Endocrinol Metab 105:1682–1699 Im GI, Lee SH (2015) Effect of teriparatide on healing of atypical femoral fractures: a systemic review. J Bone Metab 22:189 Koh JSB, Goh SK, Png MA, Kwek EBK, Howe TS (2010) Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma 24:75–81. https://doi.org/10.1097/BOT.0b013e3181b6499b Png MA, Koh JSB, Goh SK, Fook-Chong S, Howe TS (2012) Bisphosphonate-related femoral periosteal stress reactions: scoring system based on radiographic and MRI findings. Am J Roentgenol 198:869–877. https://doi.org/10.2214/AJR.11.6794 Min BW, Koo KH, Park YS, Oh CW, Lim SJ, Kim JW, Lee KJ, Lee YK (2017) Scoring system for identifying impending complete fractures in incomplete atypical femoral fractures. J Clin Endocrinol Metab 102:545–550. https://doi.org/10.1210/JC.2016-2787 Png MA, Mohan PC, Koh JSB, Howe CY, Howe TS (2019) Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up. Osteoporos Int. https://doi.org/10.1007/s00198-019-05067-7 Oh Y, Wakabayashi Y, Kurosa Y, Ishizuki M, Okawa A (2014) Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series. J Orthop Sci. https://doi.org/10.1007/s00776-014-0572-9 Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y (2012) Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: A case series. J Bone Miner Metab 30:561–567. https://doi.org/10.1007/s00774-012-0358-0 Oh Y, Fujita K, Wakabayashi Y, Kurosa Y, Okawa A (2017) Location of atypical femoral fracture can be determined by tensile stress distribution influenced by femoral bowing and neck-shaft angle: a CT-based nonlinear finite element analysis model for the assessment of femoral shaft loading stress. Injury 48:2736–2743. https://doi.org/10.1016/j.injury.2017.09.023 Zenke Y, Ikeda S, Fukuda F, Tanaka M, Tanaka H, Hirano F, Sakai A (2016) Study of atypical femoral fracture cases coupled in a multicenter study. J UOEH 38:207–214. https://doi.org/10.7888/JUOEH.38.207 Saita Y, Ishijima M, Mogami A, Kubota M, Baba T et al (2015) The incidence of and risk factors for developing atypical femoral fractures in Japan. J Bone Miner Metab 33:311–318. https://doi.org/10.1007/S00774-014-0591-9 Clanton TO, Solcher BW, Baxter DE (1994) Treatment of anterior midtibial stress fractures. Sport Med Arthrosc Rev 2:293–300 Maitra RS, Johnson DL (1997) Stress fractures. Clinical history and physical examination. Clin Sport Med 16:259–274. https://doi.org/10.1016/s0278-5919(05)70021-1 Green NE, Rogers RA, Lipscomb AB (1985) Nonunions of stress fractures of the tibia. Am J Sports Med 13:171–176. https://doi.org/10.1177/036354658501300305 Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K (2015) Risk of atypical femoral fracture during and after bisphosphonate use: full report of a nationwide study. Acta Orthop 86:100–107. https://doi.org/10.3109/17453674.2015.1004149 Adams AL, Adams JL, Raebel MA, Tang BT, Kuntz JL, Vijayadeva V, McGlynn EA, Gozansky WS (2018) Bisphosphonate drug holiday and fracture risk: a population-based cohort study. J Bone Miner Res 33:1252–1259. https://doi.org/10.1002/jbmr.3420 Watts NB, Aggers D, McCarthy EF, Savage T, Martinez S, Patterson R, Carrithers E, Miller PD (2017) Responses to treatment with teriparatide in patients with atypical femur fractures previously treated with bisphosphonates. J Bone Miner Res 32:1027–1033. https://doi.org/10.1002/jbmr.3081 Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27:2544–2550. https://doi.org/10.1002/jbmr.1719 Kwek EBK, Goh SK, Koh JSB, Png MA, Howe TS (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39:224–231. https://doi.org/10.1016/j.injury.2007.08.036 Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383:743–753. https://doi.org/10.1056/nejmoa1916525 Nguyen HH, Lakhani A, Shore-Lorenti C, Zebaze R, Vincent AJ, Milat F, Ebeling PR (2020) Asian ethnicity is associated with atypical femur fractures in an Australian population study. Bone 135:115319. https://doi.org/10.1016/j.bone.2020.115319 European Medicines Agency (EMA) (2011) Assessment report for bisphosphonates containing medicinal products Nakamura T, Matsumoto T, Sugimoto T, Hosoi T, Miki T et al (2014) Clinical trials express: Fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab 99:2599–2607. https://doi.org/10.1210/jc.2013-4175 Saita Y, Ishijima M, Mogami A, Kubota M, Baba T et al (2014) The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment. Bone 66:105–110. https://doi.org/10.1016/j.bone.2014.06.008 Mirhadi S, Ashwood N, Karagkevrekis B (2013) Factors influencing fracture healing. Trauma 15:140–155. https://doi.org/10.1177/1460408613486571